Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Short Interest Down 12.4% in January

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totaling 520,263 shares, a decrease of 12.4% from the December 31st total of 594,236 shares. Approximately 5.6% of the company’s stock are sold short. Based on an average daily trading volume, of 141,446 shares, the short-interest ratio is currently 3.7 days. Based on an average daily trading volume, of 141,446 shares, the short-interest ratio is currently 3.7 days. Approximately 5.6% of the company’s stock are sold short.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ZEPP. Fundamental Research set a $64.37 price objective on shares of Zepp Health and gave the stock a “buy” rating in a report on Tuesday, November 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Zepp Health in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Zepp Health has a consensus rating of “Hold” and an average price target of $64.37.

Zepp Health Trading Up 0.2%

Shares of ZEPP stock opened at $18.06 on Tuesday. The company has a current ratio of 1.09, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. Zepp Health has a 12-month low of $2.13 and a 12-month high of $61.85. The stock has a market capitalization of $261.78 million, a P/E ratio of -4.39 and a beta of 1.45. The firm’s 50 day moving average is $26.38 and its 200 day moving average is $33.65.

Zepp Health (NYSE:ZEPP) last announced its earnings results on Wednesday, November 5th. The company reported ($0.04) earnings per share for the quarter. The company had revenue of $75.79 million for the quarter. Zepp Health had a negative net margin of 28.28% and a negative return on equity of 21.45%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio purchased a new position in Zepp Health in the third quarter worth about $43,000. Millennium Management LLC bought a new stake in Zepp Health during the third quarter valued at approximately $11,265,000. Lighthouse Investment Partners LLC purchased a new stake in Zepp Health during the third quarter valued at approximately $2,070,000. Centiva Capital LP bought a new position in Zepp Health in the third quarter worth approximately $538,000. Finally, Oasis Management Co Ltd. purchased a new position in shares of Zepp Health during the 3rd quarter worth $276,000. Institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.